NYU Langone Health · 2 hours ago
Senior Associate Director for Clinical Research
NYU Langone Health is seeking a Senior Associate Director for Clinical Research at the Associate Professor or Professor level. The role involves leading clinical studies and participating in NIH-funded vaccine research projects, with a focus on various aspects of vaccine research including preclinical studies and immunology.
EducationHealth CareHospitalMedicalNon Profit
Responsibilities
Join an existing team of vaccine researchers and clinic/laboratory staff
Work on NIH-, industry-, and internally-funded human research projects relating to vaccines and infectious diseases
Lead clinical studies and play a senior role in the Vaccine Center and its programs including the NIH/NIAID-funded NYU Vaccine and Treatment Evaluation Unit (VTEU) and other NIH-funded programs
Qualification
Required
M.D. or M.D./Ph.D. degrees
strong expertise in vaccine research
experience in clinical research
experience in one or more areas of vaccine research such as preclinical, immunology, virology or microbiology, translational, and/or human behavior relating to vaccine hesitancy
history of work in novel vaccine platforms, high priority vaccine targets, microbial immunity, and/or vaccine immunology
history of participation in NIH-funded, high priority vaccine programs
Preferred
Candidates with an M.D. or M.D./PhD degree that are board-certified in adult Infectious Diseases will be given especially strong consideration
Company
NYU Langone Health
NYU Langone Health is a nonprofit organization that provides a center of excellence in healthcare, research, and medical education.
H1B Sponsorship
NYU Langone Health has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2023 (1)
2022 (5)
2021 (8)
2020 (35)
Funding
Current Stage
Late StageTotal Funding
$33.5MKey Investors
National Institute of Diabetes and Digestive and Kidney DiseasesMHCIPNational Institutes of Health
2024-02-06Grant· $13M
2023-10-16Grant· $12.5M
2022-02-17Grant· $8M
Leadership Team
Recent News
Business Wire
2026-01-13
Benzinga.com
2026-01-13
Company data provided by crunchbase